Clinical Trials Logo
  1. Home
  2. Symptomatic Aortic Stenosis
  3. NCT03143686

ACURATE TA™ Valve Implantation: SAVI Registry (Surveillance Plan #2011-02) (TA-SAVI)

Symptomatic Aortic Stenosis Clinical Trial

Clinical Trial Summary

Post-market registry on ACURATE TA™ Transapical Aortic Bioprosthesis and ACURATE TA™ Delivery System implantation in patients presenting severe symptomatic aortic stenosis to provide safety surveillance of the device.

Clinical Trial Description

A single arm, prospective, multicenter, non-randomized and open registry up to 1 Year Follow-up with the Symetis ACURATE TA™ which is an aortic bioprosthesis for minimal invasive implantation via transapical access to treat patients with severe symptomatic aortic stenosis where surgical aortic valve replacement (SAVR) via open surgery is considered to be associated with high surgical risk for evaluating the safety and performance of the implantation and the safety at 30-Day Follow-up. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03143686
Study type Observational
Source Boston Scientific Corporation
Contact
Status Completed
Phase
Start date November 2011
Completion date November 2013
View Details
See also
  Status Clinical Trial Phase
Completed NCT03003650 - ACURATE TF™ Transfemoral Aortic Bioprosthesis for Implantation in Patients With Severe Aortic Stenosis:CE-approval Cohort N/A
Completed NCT03314857 - China XT: Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population N/A
Active, not recruiting NCT04091048 - Optimize PRO Study
Withdrawn NCT03247465 - Image Fusion and Calcification Raising in Trans Aortic Valve Implantation N/A
Active, not recruiting NCT05182307 - DurAVR™ THV System: First-In-Human Study N/A
Active, not recruiting NCT03466918 - China S3: Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 THV in the Chinese Population N/A
Completed NCT01819181 - Women's INternational Transcatheter Aortic Valve Implantation Registry
Completed NCT04331145 - Platelet REACtivity According to TICagrelor Dose After Transcatheter AorticValve Implantation Phase 4
Recruiting NCT02803294 - Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population Phase 4
Completed NCT02536196 - The REFLECT Trial: Cerebral Protection to Reduce Cerebral Embolic Lesions After Transcatheter Aortic Valve Implantation N/A
Recruiting NCT04861805 - Pivotal Study of the Vienna Transcatheter Self Expandable Aortic Valve SE System N/A
Withdrawn NCT02088021 - Assessment of the St. Jude Medical PorticoTM Re-sheathable Aortic Valve System - Alternative Access N/A
Terminated NCT02759237 - The Medtronic Transcatheter Aortic Valve Implant System (CoreValve System Family) Post Marketing Surveillance (PMS) (CoreValve India PMS) N/A
Recruiting NCT01794832 - Severe Aortic Stenosis in Patients Referred for Valve Surgery N/A
Completed NCT02424370 - Geriatric Evaluation to Predict Mortality and Functional Recovery After Trans Aortic Valve Implantation
Completed NCT01493284 - Portico TAVI Implant With Transfemoral Delivery System N/A
Active, not recruiting NCT05712161 - Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study N/A
Completed NCT02664649 - Anti-Thrombotic Strategy After Trans-Aortic Valve Implantation for Aortic Stenosis Phase 3
Completed NCT01487330 - First in Human Experience of the St. Jude Medical TAVI Valve and Delivery System N/A
Active, not recruiting NCT04722250 - SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial N/A